GlassScriptPhysician profile
Catharine Dorozinsky
NPI 1366503922
$894.19
in general payments reported to CMS, 2019-2025
16 companies · $96.57 in 2025
The $96.57 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $39.83 · 2023: $192 · 2024: $429 · 2025: $96.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $193.33 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $150.72 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $121.30 | 2022-2024 | |
| Impulse Dynamics (USA) INC. | $83.15 | 2024 | Optimizer |
| Abbott Laboratories | $69.28 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lexicon Pharmaceuticals, INC. | $61.05 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $35.27 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.25 | 2022-2023 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $24.17 | 2024 | Arcalyst |
| Novo Nordisk INC | $23.48 | 2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.21 | 2023 | Lifevest |
| Medicomp INC | $18.02 | 2024 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $17.81 | 2025 | |
| Watermark Medical, INC. | $15.85 | 2024 | |
| Merck Sharp & Dohme LLC | $14.45 | 2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $13.85 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catharine Dorozinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.